Bushen Huatan formula alleviates polycystic ovary syndrome in rats by activating the PI3K/Akt pathway to inhibit GSDMD-mediated pyroptosis and mitochondrial damage | Journal of Ovarian Research

Louwers Y-V, Laven Joop-S-E. Characteristics of polycystic ovary syndrome throughout life[J]. Ther Adv Reprod Health.2020;14:563630270.

Ozegowska K, Marcin K, Agnieszka S, et al. Heterogeneity of endocrinologic and metabolic parameters in reproductive age polycystic ovary syndrome (PCOS) women concerning the severity of Hyperandrogenemia-A new insight on syndrome Pathogenesis[J]. Int J Environ Res Public Health. 2020;17(24):9291.

Shrivastava S, Conigliaro R-L. Polycystic ovarian Syndrome[J]. Med Clin North Am. 2023;107(2):227–234.

Google Scholar 

Rosenfield R-L. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism Revisited[J]. Endocr Rev. 2016;37(5):467–520.

Google Scholar 

Almhmoud H, Alatassi L, Baddoura M, et al. Polycystic ovary syndrome and its multidimensional impacts on women’s mental health: A narrative review[J]. Med (Baltim). 2024;103(25):e38647.

Google Scholar 

Dilliyappan S, Kumar A-S, Venkatesalu S, et al. Polycystic ovary syndrome: recent research and therapeutic advancements[J]. Life Sci. 2024;359:123221.

Akre S, Kapil S, Swarupa C, et al. Recent advances in the management of polycystic ovary syndrome: A review Article[J]. Cureus. 2022;14(8):e27689.

Google Scholar 

Miao R, Jiang C, Chang WY, et al. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis[J]. Immunity. 2023;56(11):2523–2541.e8.

Google Scholar 

Li Y-Y, Peng Y-Q, Yang Y-X, et al. Fundamental mechanisms of cell death for polycystic ovary syndrome[J]. Biochem Biophys Rep. 2025;43:102043.

An J, Zhou Q, Guo X-J, et al. From pathophysiology to treatment: the role of ferroptosis in PCOS[J]. Front Biosci (Landmark Ed). 2025;30(2):25586.

Google Scholar 

Kobayashi H, Matsubara S, Yoshimoto C, et al. A comprehensive review of the contribution of mitochondrial DNA mutations and dysfunction in polycystic ovary Syndrome, supported by secondary database Analysis[J]. Int J Mol Sci. 2025; 26(3):1172.

Sun C, Zhao S-S, Pan Z-M, et al. The role played by mitochondria in polycystic ovary Syndrome[J]. DNA Cell Biol. 2024;43(4):158–174.

Google Scholar 

Dabravolski S-A, Nikiforov N-G, Eid A-H, et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary Syndrome[J]. Int J Mol Sci. 2021; 22(8):3923.

Zhang J-S, Bao Y-G, Zhou X, et al. Polycystic ovary syndrome and mitochondrial dysfunction[J]. Reprod Biol Endocrinol. 2019;17(1):67.

Google Scholar 

Lin W, Wang Y, Zheng L. Polycystic ovarian syndrome (PCOS) and recurrent spontaneous abortion (RSA) are associated with the PI3K-AKT pathway activation[J]. PeerJ. 2024; 12:e17950.

Zhu R-Y, Yang L, Li Y-L. TXNIP participates in the pathogenesis of PCOS by regulating Glycolysis in granulosa cells[J]. Biochem Biophys Res Commun, 2025, 775:152149

Mingli An Xinping Fu, Xin Meng, et al. PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis[J]. J Reprod Immunol. 2024;162:104213.

Gong Y-H, Qiu J-S, Jiang T, et al. Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-kappaB pathway and regulating NLRP3 inflammasome-mediated pyroptosis[J]. Inflammopharmacology. 2023;3(1):369–384.

Google Scholar 

Wei B-Y, Liu W-C, Jin L, et al. Dexmedetomidine inhibits gasdermin D-Induced pyroptosis via the PI3K/AKT/GSK3beta pathway to attenuate neuroinflammation in early brain injury after subarachnoid hemorrhage in Rats[J]. Front Cell Neurosci. 2022;16:899484.

Xie X-X, Shu R-N, Yu C-N, et al. Mammalian AKT, the emerging roles on mitochondrial function in Diseases[J]. Aging Dis. 2022;13(1):157–174.

Google Scholar 

Kale J, Kutuk O, Brito G-C, et al. Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance[J]. Embo Reports.2018;19(9): e45235.

Qin J, Wang L-L, Liu Z-Y, et al. Ezetimibe protects endothelial cells against oxidative stress through Akt/GSK-3beta Pathway[J]. Curr Med Sci. 2018;38(3):398–404.

Google Scholar 

GAO M-Y, HONG Y-L, CUI M-T, et al. [Bushen Huatan recipe for treatment of polycystic ovary syndrome: therapeutic mechanism based on network Pharmacology and molecular docking][J]. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(1):1–12.

Google Scholar 

Yan-Li Hong Y-L, Wu Fei. [Effect of Bushen Huatan recipe on the Akt signal pathway in polycystic ovarian syndrome model rats with insulin resistance: an experimental research][J]. Zhongguo Zhong Xi Yi Jie He Za Zhi.2014;34(2): 230–234

Xu J-B, Dun J-J, Yang J, et al. Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal Pathways[J]. Med Sci Monit. 2020;26:e923073.

Zhao H, Zhang J-Q, Cheng X-Y, et al. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment[J]. J Ovarian Res. 2023;16(1):9.

Google Scholar 

Iervolino M, Lepore E, Forte G, et al. Natural molecules in the management of polycystic ovary syndrome (PCOS): an analytical Review[J]. Nutrients. 2021;13(5):1677.

Szukiewicz D, Trojanowski S, Kociszewska A,et al. Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)-Searching for epigenetic Factors[J]. Int J Mol Sci.2022;23(23):14663.

Olaniyi K-S, Bashir A-M, Areloegbe S-E, et al. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model[J]. PLoS ONE. 2022;17(7):e272124.

Google Scholar 

Begum N, Manipriya K, Veeresh B.. Role of high-fat diet on letrozole-induced polycystic ovarian syndrome in rats[J]. Eur J Pharmacol. 2022;917:174746.

Jena S, Mishra I, Baliarsinha A-K, et al. Variation in clinical Presentation, metabolic Profile, hormonal parameters and inflammatory markers in polycystic ovary syndrome women with and without polycystic ovary morphology Appearance[J]. J Hum Reprod Sci. 2023;16(2):132–139.

Google Scholar 

Rakic D, Joksimovic Jovic J, Jakovljevic V, et al. High fat diet exaggerate metabolic and reproductive PCOS features by promoting oxidative stress: an improved EV model in Rats[J]. Medicina. 2023;59(6):1104.

Google Scholar 

Qi S-Q, Yu H-Y, Hu W, et al. Evaluation of representativeness and sustainability of PCOS rat models induced by letrozole with or without high-fat diet[J]. Sci Rep. 2025;15(1):30754.

Google Scholar 

Shen W-J, Jin B, Pan Y-J, et al. The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome[J]. Evid Based Complement Alternat Med. 2021;2021:6619597.

Li T, Wei Y, Jiao B-B, et al. Bushen Huoxue formula attenuates lipid accumulation evoking excessive autophagy in premature ovarian insufficiency rats and palmitic acid-challenged KGN cells by modulating lipid metabolism[J]. Front Pharmacol. 2024;15:1425844.

Google Scholar 

Shah MZUH, Shrivastva VK, Mir MA, et al. Effect of Quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome[J]. Front Endocrinol. 2023;14:1153289.

Google Scholar 

Zhang X-Y, Zhang N, Dong Z-B , et al. The role of Chinese herbal medicine in diminished ovarian reserve management[J]. J Ovarian Res. 2025;18(1):90.

Google Scholar 

Hadi S, Khoshraftar SH, Kiani Darabi AH, et al. Extracellular fluid miRNAs in PCOS[J]. Clin Chim Acta. 2025;576:120404.

Du G, Healy LB, David L, et al. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D[J]. Nature. 2024;630(8016):437–46.

Cui M-T, Hong Y-L, Huang J-Y, et al. [Efficiency of Chinese medicine Bushen Huatan formula for treatment of polycystic ovary syndrome in mice via regulating gut microbiota and PPARgamma pathway][J]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(1):33–45.

Google Scholar 

Singh S, Pal N, Shubham S, et al. Polycystic ovary syndrome: Etiology, current Management, and future Therapeutics[J]. J Clin Med. 2023;12(4):1454.

Google Scholar 

Chen T-Q, Xie S-Y, Cheng J, et al. AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to Glycolysis for tumorigenesis[J]. Nat Commun. 2024;15(1):686.

Google Scholar 

Wang K-X, Li Y-H. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome[J]. Front Endocrinol (Lausanne). 2023;14:1191759.

Deng P-J, Liu J-J-J-G. Diverse activation mechanisms of PI3Ks[J]. Nat Struct Mol Biol. 2022;29(3):185–187.

Google Scholar 

He X-G, Li Y, Deng B, et al. The PI3K/AKT signalling pathway in inflammation, cell death and glial Scar formation after traumatic spinal cord injury: mechanisms and therapeutic opportunities[J]. Cell Prolif. 2022;55(9):e13275.

Google Scholar